These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31016667)

  • 1. Patient-Derived Organoids from Human Bile: An In Vitro Method to Study Cholangiopathies.
    Soroka CJ; Assis DN; Boyer JL
    Methods Mol Biol; 2019; 1981():363-372. PubMed ID: 31016667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile.
    Soroka CJ; Assis DN; Alrabadi LS; Roberts S; Cusack L; Jaffe AB; Boyer JL
    Hepatology; 2019 Sep; 70(3):871-882. PubMed ID: 30561836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients.
    Frank AK; Chung BK; De Novales MLL; Engesæter LK; Hoyle HW; Øgaard J; Heslop J; Karlsen TH; Tysoe O; Brevini T; Tchorz JS; Vallier L; Mohorianu I; Sampaziotis F; Melum E
    Dig Dis Sci; 2024 Oct; 69(10):3810-3823. PubMed ID: 39160386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
    Adams DH; Hubscher SG; Shaw J; Johnson GD; Babbs C; Rothlein R; Neuberger JM
    Hepatology; 1991 Sep; 14(3):426-31. PubMed ID: 1714872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis--a study of bile cultures from ERCP.
    Björnsson ES; Kilander AF; Olsson RG
    Hepatogastroenterology; 2000; 47(36):1504-8. PubMed ID: 11148988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Biliary Organoids in Cholestasis Research.
    Sampaziotis F; Tysoe O; Brevini T; Vallier L
    Methods Mol Biol; 2019; 1981():373-382. PubMed ID: 31016668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets.
    Grama A; Mititelu A; Sîrbe C; Benţa G; Pop TL
    Front Immunol; 2023; 14():1206025. PubMed ID: 37928553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of primary intrahepatic sclerosing cholangitis (PISC) complicated with atypical biliary epithelial proliferation.
    Aizawa K; Kawaguchi S; Doi M; Mizuno W; Uragami K; Oka T; Miyamoto H; Itoh H; Nishioka S
    Intern Med; 1992 Jan; 31(1):114-21. PubMed ID: 1568030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.
    Pollheimer MJ; Fickert P; Stieger B
    Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.
    Trussoni CE; O'Hara SP; LaRusso NF
    Semin Immunopathol; 2022 Jul; 44(4):527-544. PubMed ID: 35178659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.
    Olsson R; Björnsson E; Bäckman L; Friman S; Höckerstedt K; Kaijser B; Olausson M
    J Hepatol; 1998 Mar; 28(3):426-32. PubMed ID: 9551680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.
    Carpino G; Cardinale V; Renzi A; Hov JR; Berloco PB; Rossi M; Karlsen TH; Alvaro D; Gaudio E
    J Hepatol; 2015 Nov; 63(5):1220-8. PubMed ID: 26119688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR cholangiopancreatography in patients with primary sclerosing cholangitis: interobserver variability and comparison with endoscopic retrograde cholangiopancreatography.
    Vitellas KM; El-Dieb A; Vaswani KK; Bennett WF; Tzalonikou M; Mabee C; Kirkpatrick R; Bova JG
    AJR Am J Roentgenol; 2002 Aug; 179(2):399-407. PubMed ID: 12130441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
    Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis.
    Reinhard L; Rupp C; Riedel HD; Ruppert T; Giese T; Flechtenmacher C; Weiss KH; Kloeters-Plachky P; Stremmel W; Schirmacher P; Sauer P; Gotthardt DN
    PLoS One; 2012; 7(1):e29821. PubMed ID: 22253789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
    Fickert P; Stöger U; Fuchsbichler A; Moustafa T; Marschall HU; Weiglein AH; Tsybrovskyy O; Jaeschke H; Zatloukal K; Denk H; Trauner M
    Am J Pathol; 2007 Aug; 171(2):525-36. PubMed ID: 17600122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biliary HCO(3)(-) umbrella: experimental evidence revisited.
    Beuers U; Maroni L; Elferink RO
    Curr Opin Gastroenterol; 2012 May; 28(3):253-7. PubMed ID: 22450897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of cholestasis: An update on inflammatory cholangiopathies.
    Mariotti V; Cadamuro M; Spirli C; Fiorotto R; Strazzabosco M; Fabris L
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):954-964. PubMed ID: 30398152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma.
    Sato K; Zhang W; Safarikia S; Isidan A; Chen AM; Li P; Francis H; Kennedy L; Baiocchi L; Alvaro D; Glaser S; Ekser B; Alpini G
    Hepatology; 2021 Jul; 74(1):491-502. PubMed ID: 33222247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.